Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis.
bleeding
erythropoiesis
fibrinolysis
hemostasis
heparin
mast cell disease
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Aug 2021
20 Aug 2021
Historique:
received:
22
07
2021
revised:
10
08
2021
accepted:
17
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
18
9
2021
Statut:
epublish
Résumé
Mast cell disease is an epigenetically and genetically determined disease entity with very diverse clinical manifestations in potentially every system and tissue due to inap pro priate release of variable subsets of mast cell mediators together with accumulation of either morphologically normal or altered mast cells. Easy bruising, excessive bleeding, and aberrancies of erythropoiesis can frequently be observed in patients with mast cell disease. A thorough history, including a family history, will guide the appropriate work-up, and laboratory evaluations may provide clues to diagnosis. In recent years, our understanding of the involvement of coagulation and anticoagulant pathways, the fibrinolytic system, and erythropoiesis in the pathophysiology of mast cell disease has increased considerably. This review summarizes current knowledge of the impact of the disturbed hemostatic and erythropoietic balance in patients with mast cell disease and describes options of treatment.
Identifiants
pubmed: 34445665
pii: ijms22168960
doi: 10.3390/ijms22168960
pmc: PMC8396658
pii:
doi:
Substances chimiques
Anticoagulants
0
Fibrinolytic Agents
0
Heparin
9005-49-6
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Drugs. 1999 Jun;57(6):1005-32
pubmed: 10400410
J Cardiothorac Surg. 2011 Oct 14;6:138
pubmed: 21999189
Int J Mol Sci. 2020 Jul 31;21(15):
pubmed: 32752121
Biochem J. 1991 Jun 15;276 ( Pt 3):739-43
pubmed: 1648351
Immunol Lett. 2018 Jul;199:23-35
pubmed: 29635001
Pol Arch Intern Med. 2018 Aug 31;128(7-8):491-493
pubmed: 30057374
Immunol Rev. 2007 Jun;217:105-22
pubmed: 17498055
PLoS One. 2015 Apr 24;10(4):e0124912
pubmed: 25909362
Thromb Haemost. 2002 May;87(5):786-90
pubmed: 12038777
Clin Appl Thromb Hemost. 2008 Jul;14(3):360-4
pubmed: 18160568
Blood. 1979 Sep;54(3):684-93
pubmed: 380688
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Drugs. 2012 Mar 26;72(5):585-617
pubmed: 22397329
Hum Pathol. 2017 Apr;62:180-186
pubmed: 28159675
J Thromb Haemost. 2015 Jun;13 Suppl 1:S92-7
pubmed: 26149055
Acta Pathol Jpn. 1991 May;41(5):344-9
pubmed: 1651041
Oncology (Williston Park). 2014 Feb;28(2):129-31, 134
pubmed: 24701700
Am J Pathol. 1986 Mar;122(3):469-80
pubmed: 3513601
J Biol Chem. 2012 Mar 9;287(11):7834-44
pubmed: 22235124
Thromb Res. 2013 Feb;131(2):150-7
pubmed: 23260446
Clin Orthop Relat Res. 1983 Nov;(180):260-7
pubmed: 6354546
Acta Pathol Microbiol Immunol Scand A. 1982 Nov;90(6):437-9
pubmed: 6187180
Immunogenetics. 2017 Jun;69(6):359-369
pubmed: 28386644
J Thromb Haemost. 2008 Nov;6(11):1962-9
pubmed: 18752579
PLoS One. 2013 Sep 30;8(9):e76241
pubmed: 24098785
J Environ Pathol Toxicol Oncol. 2009;28(3):223-30
pubmed: 19888909
Naunyn Schmiedebergs Arch Pharmacol. 2016 Jul;389(7):671-94
pubmed: 27132234
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2235-2242
pubmed: 33744473
Int J Hematol. 2010 Jun;91(5):907-8
pubmed: 20526893
Thromb Haemost. 2011 Nov;106(5):987-9
pubmed: 21901238
Front Med (Lausanne). 2019 Apr 12;6:76
pubmed: 31106204
J Pathol. 2019 Apr;247(4):505-512
pubmed: 30506885
J Biomech. 2013 Feb 22;46(4):788-95
pubmed: 23261248
Am J Med Sci. 2017 Mar;353(3):207-215
pubmed: 28262205
J Allergy Clin Immunol. 1977 Jul;60(1):38-40
pubmed: 874207
Int J Mol Sci. 2020 Nov 27;21(23):
pubmed: 33260972
Immunol Lett. 2016 Oct;178:10-4
pubmed: 27393494
Crit Care. 2007;11(6):R117
pubmed: 17988379
Experientia. 1954 Mar 15;10(3):148-52
pubmed: 13161899
Am J Hum Genet. 2021 Feb 4;108(2):284-294
pubmed: 33421400
Thromb Haemost. 2011 Nov;106(5):820-6
pubmed: 21866302
Circ Res. 2017 Sep 29;121(8):941-950
pubmed: 28739590
Int J Mol Sci. 2020 Dec 30;22(1):
pubmed: 33396702
Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):438-41
pubmed: 15692257
Adv Exp Med Biol. 2019;1165:381-406
pubmed: 31399975
Case Rep Hematol. 2018 Jul 8;2018:6928571
pubmed: 30069418
Chirurg. 2019 Jul;90(7):548-556
pubmed: 30874862
Z Gastroenterol. 2011 Feb;49(2):191-4
pubmed: 21298604
Front Immunol. 2017 Jul 26;8:846
pubmed: 28798744
Medicine (Baltimore). 2015 Oct;94(40):e1414
pubmed: 26447996
J Invest Dermatol. 1999 Jul;113(1):93-7
pubmed: 10417625
Br J Dermatol. 2019 Aug;181(2):296-303
pubmed: 30561017
Semin Thromb Hemost. 2018 Oct;44(7):669-675
pubmed: 29920622
Cases J. 2008 Aug 18;1(1):100
pubmed: 18706126
Int J Infect Dis. 2020 Nov;100:327-332
pubmed: 32920235
Br J Rheumatol. 1997 Mar;36(3):393-6
pubmed: 9133977
J Biol Chem. 1988 Jul 5;263(19):9360-5
pubmed: 3132461
Blood. 2008 Mar 15;111(6):3070-80
pubmed: 18182576
J Obstet Gynaecol. 2019 Jul;39(5):664-669
pubmed: 30964355
J Investig Allergol Clin Immunol. 2013;23(7):517-8
pubmed: 24654321
Sci Adv. 2020 Mar 18;6(12):eaay6314
pubmed: 32206714
Blood. 2017 Jan 19;129(3):371-382
pubmed: 27856463
Nat Immunol. 2016 Jul;17(7):878-87
pubmed: 27135604
Ann Med. 2016;48(3):190-201
pubmed: 27012973
Blood. 2009 Jun 4;113(23):5727-36
pubmed: 19363219
Am J Med Sci. 2011 Jul;342(1):44-9
pubmed: 21642812
Thromb Res. 1983 Jul 15;31(2):365-74
pubmed: 6636048
Immunol Allergy Clin North Am. 2014 May;34(2):263-81
pubmed: 24745673
Cureus. 2016 Jun 03;8(6):e629
pubmed: 27433408
Trends Cardiovasc Med. 2021 Jan;31(1):1-5
pubmed: 33068723
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2284-7
pubmed: 3353378
J Immunol. 1999 Jan 15;162(2):1032-41
pubmed: 9916730
Semin Thromb Hemost. 1978 Spring;4(4):326-49
pubmed: 97786